Case guide

Should I Get a Scan After the Depo Shot?

Used the Depo shot and wonder about a brain scan? Ask your clinician what test fits your symptoms and history.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202618 sources

This may apply to you if

  • Have your shot name and dates ready for a lawyer to review.
  • Have the report that names your meningioma, a tumor in tissue around the brain.
  • If you already have a lawyer, ask whether your claim is eligible for the reported program.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

M. Casey Rodgers · U.S. District Court, Northern District of Florida · United States District Judge

Finding: The August 10, 2026 order describes an agreement for many existing federal claims and separate court procedures for continuing litigation. Ask a lawyer which track applies to you.

Case Management Order No. 14 (opens in a new tab) · Aug 10, 2026 · Checked Oct 3, 2026

Noémie Roland · EPI-PHARE, French National Agency for Medicines and Health Products Safety and French National Health Insurance · First-listed study author

Finding: The 2024 BMJ study found an association between injectable medroxyprogesterone use and meningioma surgery in French health records. A small exposed group and observational design limit what it can show about an individual.

Use of progestogens and the risk of intracranial meningioma: national case-control study (opens in a new tab) · Mar 27, 2024 · Checked Oct 3, 2026

The evidence and its limits

EPI-PHARE · BMJ · 2024

French health-record study of hormone medicines and meningioma surgery

Design:
Case-control
Participants:
108,366 women: 18,061 surgery cases and 90,305 matched controls
Finding:
Injectable medroxyprogesterone acetate use was associated with higher odds of surgery for meningioma; the excess was linked to prolonged use.
Main limitation
Observational French data; only nine exposed cases and eleven exposed controls for this injection. The study does not prove that the shot caused any one person’s tumor or define who qualifies for a claim.

Read the source: French health-record study of hormone medicines and meningioma surgery (opens in a new tab) · Checked Oct 3, 2026

National Health Service (UK) · 2025

NHS patient care guidance, reviewed February 2025

Design:
Other study design
Participants:
Not applicable: public patient guidance, not a study sample
Finding:
The guidance describes symptom assessment and when to seek medical help for possible brain-tumor symptoms.
Main limitation
General UK care guidance; not a Depo causation study, personal diagnosis, MRI screening rule or US service guarantee.

Read the source: NHS patient care guidance, reviewed February 2025 (opens in a new tab) · Checked Oct 3, 2026

National Health Service (UK) · 2025

NHS MRI preparation guidance, reviewed September 2025

Design:
Other study design
Participants:
Not applicable: public scan guidance, not a study sample
Finding:
The guidance explains MRI preparation, safety questions and communication of findings.
Main limitation
General UK service guidance; personal test choice, contrast, price, coverage and timing need the actual care team.

Read the source: NHS MRI preparation guidance, reviewed September 2025 (opens in a new tab) · Checked Oct 3, 2026

The short answer

Does the FDA warning require every user to get an MRI?
The label’s tumor warning says to monitor signs and symptoms. That warning does not set an MRI schedule for every user. Ask the clinician how it applies to you. [3]
What can a brain scan show?
An MRI makes images that can help the care team check a problem. A scan alone does not show the cause of a tumor. It does not settle a claim. [17]
When should symptoms prompt medical help?
Get urgent help for a first seizure or sudden, very painful headache. Do not wait for a planned scan. Ask a doctor about symptoms that last or get worse. [18]
What should I tell the scan team before the visit?
Ask the scan team how to get ready. Tell it about implants, kidney problems and allergies. Ask if a dye is planned and discuss your concerns before the visit. [17]

What rules a case out

Not covered by this case

  • Symptoms or shot use alone do not prove a meningioma claim.
  • A study association does not establish the cause of your own tumor.
  • Care guidance does not set universal scan, program or firm acceptance rules.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Used the Depo shot and wonder about a brain scan? Ask your clinician what test fits your symptoms and history. A scan can help with care; it does not decide the cause or value of a legal claim.

Does the FDA warning require every user to get an MRI?

The label’s tumor warning says to monitor signs and symptoms. That warning does not set an MRI schedule for every user. Ask the clinician how it applies to you.

The December 2025 warning reports meningiomas after repeated use, mainly long-term use. It directs clinicians to stop Depo-Provera CI if meningioma is diagnosed. It does not give a screening age or years-of-use threshold in that section.

Tell the clinician the product, shot dates and any changes you have noticed. Ask whether a test is needed now, why it is proposed and what would happen after it. Do not turn a lawsuit advertisement into a personal scan order.

What can a brain scan show?

An MRI makes images that can help the care team check a problem. A scan alone does not show the cause of a tumor. It does not settle a claim.

NHS brain-tumor guidance describes scans as a way to look for a possible tumor. Further tests may be needed to confirm the finding. This is general guidance, not a rule that all Depo users need the same test.

Ask the team what the report found and what remains uncertain. If it names a meningioma, ask what that means for follow-up. Keep a copy of the report and request an explanation of words that are unfamiliar.

When should symptoms prompt medical help?

Get urgent help for a first seizure or sudden, very painful headache. Do not wait for a planned scan. Ask a doctor about symptoms that last or get worse.

The NHS guide treats those sudden symptoms as emergencies. Use the local emergency service where you are; its UK numbers are not US care instructions. Tell the team what happened and when, without deciding the diagnosis yourself.

If a scan has already been ordered, ask who to call if symptoms change before it. Keep that number with the appointment instructions. A claim review is a separate task and should not delay needed care.

What should I tell the scan team before the visit?

Ask the scan team how to get ready. Tell it about implants, kidney problems and allergies. Ask if a dye is planned and discuss your concerns before the visit.

The NHS MRI guide describes safety questions about metal in the body, pregnancy and allergies. It says some scans use contrast to show more detail. These are items to discuss with your team, not instructions to remove an implant or require dye.

Say if a confined space makes you anxious. Ask what support is available and what any medicine would mean for travel home. Use your center’s actual instructions rather than assuming a duration, price or result date from another health system.

What does the Depo study tell me about screening?

The French study found a link with surgery for this tumor. It did not set a scan plan for every shot user. It does not prove the cause in one person.

Only nine surgery cases and eleven controls had used the injection in the study’s exposed group. That small group limits what the finding can show. A higher group-level association is not the chance that your scan will find a tumor.

Ask the clinician to weigh your own history when discussing a test. Ask the lawyer a separate question about whether the medical findings support a claim. Neither answer should be inferred from a study headline.

How should I keep results and check costs?

Ask for the report and who will explain it. Before booking, ask about the charge and your share. Check with the scan center and health plan; payment is not promised here.

The NHS MRI guide says a specialist reads the images and reports to the referring doctor. Ask your own center how results will reach you and whom to contact if they do not arrive. Its UK wait times are not a promise for your appointment.

Covered medical records generally have an access route under federal rules, with exceptions. Ask how to get the report and, if needed, copies of the images. Keep the request and reply. Sharing those records with a legal service needs its own privacy and permission check.

If you seek legal help, ask about the firm’s fee and expenses in writing. Have a lawyer review your dates and law instead of treating a scan date as an automatic filing deadline. A scan bill is not proof that the expense will be paid by a lawsuit.

Scientific evidence for this case

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Questions about this guide

My doctor says I don't need an MRI. What should I do?

It depends. Ask your treating clinician about symptoms, testing, or medication changes. The FDA label says to monitor for signs and symptoms of meningioma and to discontinue Depo-Provera CI if a meningioma is diagnosed. A claim page cannot diagnose you or decide your medical care.

Source: FDA Depo-Provera CI label, revised December 2025 · as of Oct 7, 2026

How often should I get an MRI if a meningioma is found?

After initial meningioma detection, typical monitoring schedules include: MRI every 3–6 months for the first year, then every 6–12 months for years 2–5, then annually thereafter (for stable, non-surgical meningiomas). Surgical patients typically get an MRI 3 months post-surgery, then follow a similar surveillance schedule. Your neurosurgeon will customize the schedule based on tumor characteristics.

Does insurance cover MRI screening for Depo-Provera users?

Insurance typically covers diagnostic MRI when ordered by a physician for symptoms. Screening MRI in asymptomatic patients may be harder to get covered. With the December 2025 FDA label update, physicians can now cite the official label recommendation to "monitor" for meningioma signs and symptoms as justification for imaging in symptomatic patients. Keep all bills — imaging costs are recoverable in your lawsuit.

Sources

  1. Court order 14: settlement and ongoing casesCourt order 14: settlement and ongoing cases · court
  2. JPML pending cases report, October 1, 2026JPML pending cases report, October 1, 2026 · court
  3. FDA Depo-Provera CI label, December 2025FDA Depo-Provera CI label, December 2025 · regulator
  4. National Cancer Institute: meningiomaNational Cancer Institute: meningioma · regulator
  5. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  6. Medical record access: 45 CFR 164.524Medical record access: 45 CFR 164.524 · regulator
  7. SDNY court guide: filing time limitsSDNY court guide: filing time limits · court
  8. Court common-benefit fee order 2Court common-benefit fee order 2 · court
  9. BMJ 2024 original author abstract via PubMedBMJ 2024 original author abstract via PubMed · study
  10. Medroxyprogesterone Acetate and Meningioma: A Global IssueFrontiers in Global Womens Health · 2025 · study
  11. Use of High-Dose Medroxyprogesterone Acetate and Risk of Intracranial MeningiomaThe BMJ · 2024 · study
  12. The Association between Medroxyprogesterone Acetate Exposure and MeningiomaCancers · 2024 · study
  13. Pfizer Reaches Agreement in Principle to Resolve Federal Depo-Provera MDLlaw360.com · Jun 15, 2026 · court
  14. JAMA Network Open Study Reports 4.5x Meningioma Risk with Medroxyprogesteronepubmed.ncbi.nlm.nih.gov · Jul 1, 2026 · study
  15. On June 15, 2026, MDL 3140 (N.D. Fla.) Leadership Counsel announced a settlement with the Pfizer defendants of a majority of the claims in the MDL and New York state court over Depo-Provera meningioma claims (Case Management Order No. 12, filed July 27, 2026). Financial terms NOT disclosed; eligibility and compensation amounts not released; deal pending finalization at the time (Case Management Order No. 14, filed Aug. 10, 2026, later described a settlement agreement dated July 22, 2026 and states no compensation amounts). The JPML reported 5,830 actions pending in MDL 3140 on July 1, 2026 and 6,412 on October 1, 2026.flnd.uscourts.gov · Jun 15, 2026 · court
  16. Settlement in principle announced; docket had grown +1,739 filings (+46%) in the single preceding month — the leading-indicator pattern.jpml.uscourts.gov · Jun 15, 2026 · court
  17. NHS: MRI scan guidance
  18. NHS: non-cancerous brain tumor guidance

Checked against 16 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026